Back to search
FDAFDA · Food and drugs·Recall number D-1459-2016

Venlafaxine Hydrochloride Extended-Release Capsules, 75 mg, 90 capsules per bottle, Rx Only, GSMS, NDC # 60429-122-90

Published August 24, 2016 · Recall initiated: August 3, 2016

Summary

FDA records drug Class II recall D-1459-2016, published August 24, 2016 and initiated August 3, 2016. Recalling firm: Golden State Medical Supply Inc.; Status: Terminated; Reported quantity: 40,631 bottles; Lot: Lot #: GS011692, GS011938, Exp 10/2017; GS012638, GS012639, Exp 11/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Out-of-specification results in retained sample.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Golden State Medical Supply Inc.
Distributor
Nationwide
Lot
Lot #: GS011692, GS011938, Exp 10/2017; GS012638, GS012639, Exp 11/2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Venlafaxine Hydrochloride Extended-Release Capsules, 75 mg, 90 capsules per bottle, Rx Only, GSMS, NDC # 60429-122-90 recalled?

Yes. FDA published recall D-1459-2016 on August 24, 2016. Reported hazard: Failed Dissolution Specifications: Out-of-specification results in retained sample.

What should I do if I have this product?

Voluntary: Firm initiated · Letter